Bottlenecks in HIV-1 transmission: insights from the study of founder viruses
about
HIV-Host Interactions: Implications for Vaccine DesignIdentifying Recent HIV Infections: From Serological Assays to GenomicsDifferences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder VirusShort-Sighted Virus Evolution and a Germline Hypothesis for Chronic Viral Infections.Seminal plasma induces inflammation and enhances HIV-1 replication in human cervical tissue explants.Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parameters.Digitally Barcoding Mycobacterium tuberculosis Reveals In Vivo Infection Dynamics in the Macaque Model of TuberculosisGlycosylation of the core of the HIV-1 envelope subunit protein gp120 is not required for native trimer formation or viral infectivity.Analysis of Viral Diversity in Relation to the Recency of HIV-1C Infection in BotswanaSaturation Mutagenesis of the HIV-1 Envelope CD4 Binding Loop Reveals Residues Controlling Distinct Trimer Conformations.Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages.Early antiretroviral treatment (eART) limits viral diversity over time in a long-term HIV viral suppressed perinatally infected child.Delineating CD4 dependency of HIV-1: Adaptation to infect low level CD4 expressing target cells widens cellular tropism but severely impacts on envelope functionality.Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairsMonocytes but Not Lymphocytes Carrying HIV-1 on Their Surface Transmit Infection to Human Tissue Ex Vivo.Targeted Delivery of Glucan Particle Encapsulated Gallium Nanoparticles Inhibits HIV Growth in Human Macrophages.Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitnessQuantifying perinatal transmission of Hepatitis B viral quasispecies by tag linkage deep sequencing.Clonal expansion of genome-intact HIV-1 in functionally polarized Th1 CD4+ T cells.Transient Oral Human Cytomegalovirus Infections Indicate Inefficient Viral Spread from Very Few Initially Infected Cells.Brain Invasion by CD4(+) T Cells Infected with a Transmitted/Founder HIV-1BJZS7 During Acute Stage in Humanized Mice.Complex immune correlates of protection in HIV-1 vaccine efficacy trials.Virus-Host Gene Interactions Define HIV-1 Disease Progression.Eradication of HIV-1 latent reservoirs through therapeutic vaccination.Quantitative analyses reveal distinct sensitivities of the capture of HIV-1 primary viruses and pseudoviruses to broadly neutralizing antibodies.HIV-1 strains belonging to large phylogenetic clusters show accelerated escape from integrase inhibitors in cell culture compared with viral isolates from singleton/small clusters.Interferon-I: The Pièce de Résistance of HIV-1 Transmission?Characterization of founder viruses in very early SIV rectal transmission.HIV sequence diversity during the early phase of infection is associated with HIV DNA reductions during antiretroviral therapy.Transmitted/Founder HIV-1 Subtype C Viruses Show Distinctive Signature Patterns in Vif, Vpr, and Vpu That Are Under Subsequent Immune Pressure During Early Infection.Protection against a mixed SHIV challenge by a broadly neutralizing antibody cocktail.The HIV-1 transmission bottleneck.Shared Genomic Variants: Identification of Transmission Routes Using Pathogen Deep-Sequence Data.Early sites of virus replication after oral SIVmac251 infection of infant macaques: implications for pathogenesis.Molecular evolution of HIV-1 integrase during the 20 years prior to the first approval of integrase inhibitors.Myeloid Cell Interaction with HIV: A Complex Relationship.HLA Class I Downregulation by HIV-1 Variants from Subtype C Transmission Pairs.Genotypic and Phylogenetic Insights on Prevention of the Spread of HIV-1 and Drug Resistance in "Real-World" Settings.Comparison of cluster-based and source-attribution methods for estimating transmission risk using large HIV sequence databases.Benzyl-2-Acetamido-2-Deoxy-α-d-Galactopyranoside Increases Human Immunodeficiency Virus Replication and Viral Outgrowth Efficacy In Vitro.
P2860
Q26765966-1A3CCB89-5290-4DB4-B323-8F8B471F6E5DQ26778001-AAD77EAB-07E6-4395-BA09-C6D0A83A8ACEQ28551914-DB90EBD3-4975-46E1-A938-6A94965B69B1Q30234948-BF71CD3C-AF79-4106-985C-0962995A0B54Q33390855-DEE56F7E-0FC8-4C92-8712-9C8D2C2B7338Q33638320-4BCD0592-E126-4A32-A77C-5ADC1D7C3775Q33654519-ED1ED9C6-FFCD-4F23-9B89-28F5289854C0Q34555891-E8E39B21-750B-4951-B971-14A336976CB4Q36110367-9CE8BD6F-2B8F-403A-8159-081653D40EF1Q36184440-C4C94051-B096-42B2-B7CD-2A39ED8636E5Q36205668-D977A268-9C77-4486-9AD6-AD57DCF0451FQ36219112-BAE7D734-9E97-4A2C-A906-D3EAB5A6983EQ36298503-399962ED-4A4E-4BDC-9FB6-55AA3C8FBF6DQ37233074-A4D3CC18-9CC7-42F8-A362-7A16076D1829Q37347339-71C3DBE0-213D-4E9B-9F30-905FA14B49C8Q37443661-559A13E0-53D1-42B3-86B2-6B2A746C46F6Q37612507-6DE070D9-AFDD-4118-9CC4-BC65BCA5BA1AQ38599096-56F0FBF5-758C-4709-B4F7-C6EF8BF75D64Q38719409-9BEA22D7-23EC-4E17-AE99-828D83B87B41Q38850665-752EE967-AFE3-480E-960B-9BF7FB2270D4Q38912920-AB46D5CB-4489-42EC-8559-77EA06400D44Q39108779-2D938463-FC99-4CD2-A038-B01F5AD5E3BCQ39400038-B89560A1-E677-46CB-97B7-B26F0E00BA7CQ40047242-894730B2-33AD-4CB1-984F-851FFEFD3539Q40174154-DD901C16-1AFE-40D5-A8AC-3D474DAA09CAQ40215127-411B0B96-A7E9-4CE2-B70A-DD24688D8478Q40295797-C96611DA-A904-479B-8A06-AB25238F1D78Q40393973-6FAF1B17-2AF5-4DC3-B5FD-E44DC506BA60Q40478109-B4418EA0-BB55-4640-BA53-30D5BF8F4C9EQ40634933-EBDD130A-8F25-41E3-87E5-0DAD97BA731EQ41933482-B5FC876E-EBB7-4041-A2EA-9E9D4D2B61A7Q42314454-B9156B60-F0A8-483B-B366-1005D6B0ECA4Q44106270-E0C1A911-BE66-4704-93C1-209CAB78DA92Q46046314-BD1617CF-D036-405E-937C-7FC573FE3974Q47130258-79895268-E250-43B4-9A29-FBC959D86894Q47141408-FDEF960C-DE0A-44F2-A538-8BFB0DB0B29FQ47555873-2279F7DF-71F7-41AE-9696-2DF84E9DB962Q47560008-9F516D96-1321-4799-A643-DAACC7C2B47DQ47625016-0E6A3AB7-D4B3-402A-B0AE-34BC235D0EDCQ50334467-4DCF94EF-133C-4B57-91A9-A7B4E5B0E78E
P2860
Bottlenecks in HIV-1 transmission: insights from the study of founder viruses
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Bottlenecks in HIV-1 transmission: insights from the study of founder viruses
@ast
Bottlenecks in HIV-1 transmission: insights from the study of founder viruses
@en
Bottlenecks in HIV-1 transmission: insights from the study of founder viruses
@nl
type
label
Bottlenecks in HIV-1 transmission: insights from the study of founder viruses
@ast
Bottlenecks in HIV-1 transmission: insights from the study of founder viruses
@en
Bottlenecks in HIV-1 transmission: insights from the study of founder viruses
@nl
prefLabel
Bottlenecks in HIV-1 transmission: insights from the study of founder viruses
@ast
Bottlenecks in HIV-1 transmission: insights from the study of founder viruses
@en
Bottlenecks in HIV-1 transmission: insights from the study of founder viruses
@nl
P2860
P3181
P356
P1476
Bottlenecks in HIV-1 transmission: insights from the study of founder viruses
@en
P2093
Angela D. M. Kashuba
Sarah B. Joseph
P2860
P2888
P304
P3181
P356
10.1038/NRMICRO3471
P407
P577
2015-07-01T00:00:00Z
P5875
P6179
1003648870